Beijing Beilu Pharmaceutical

Beijing Beilu Pharmaceutical is a specialized entity operating within the global pharmaceuticals and healthcare sectors. Founded in 1992, the company maintains a focused operational footprint with one primary location in Beijing, China. The organization currently supports a workforce of 500-1,000 employees, driving its research, development, and distribution capabilities. Meet Beijing Beilu Pharmaceutical's team to understand the leadership structure and technical expertise guiding their pharmaceutical product lifecycle management.

The company is publicly traded on the Shenzhen Stock Exchange under the ticker SZSE: 300016. Beijing Beilu Pharmaceutical leverages its established market position to deliver specialized healthcare solutions, adhering to rigorous industry standards. With a revenue profile of $125.0M, the firm demonstrates consistent fiscal activity within the competitive Asia-Pacific pharmaceutical landscape. Their operational model emphasizes B2B engagement, ensuring that their product portfolio meets the complex demands of modern healthcare providers and clinical institutions across the region.

Strategically headquartered at Maples International Office Block A, 32 Xizhimen North, Beijing, the company utilizes its central location to manage supply chain logistics and regulatory compliance. By focusing on core pharmaceutical competencies, Beijing Beilu Pharmaceutical continues to refine its market approach and service delivery. The firm remains committed to advancing healthcare outcomes through its established infrastructure and professional team, positioning itself as a stable participant in the evolving Chinese pharmaceutical market while maintaining a clear focus on long-term growth and operational excellence.